Project Euthyna

Open the recordEvery jurisdiction we cover, drawn from the primary sources.

Congress MembersEveryone who serves in the House and the Senate — the people the rest of the record is about.LegislationBills, resolutions, and the laws they become — from introduction to enactment.NominationsThe appointments the Senate reviews and confirms — judges, cabinet officials, and ambassadors.VotesThe roll-call record: how each measure moved, and how each member voted.CommitteesWhere most of the work is done — assignments, hearings, and markups.

Home/The Record/Washington/Legislation

/ yoo·THEE·nah /

Democracy works when citizens show up. We make that power easy to use.

About Project Euthyna

See what the people who represent you are doing, and how to reach them.

Built from official government primary sources.Follow: Bluesky · FacebookGet the app: App Store · Google PlayAccessibility Privacy Terms

Washington HB 2613 (2025-26): votes and status — Project Euthyna

Washington · 2025-2026 Biennium (69th Legislature)

Establishing safety and regulatory requirements for compounded medications.

AN ACT Relating to establishing safety and regulatory requirements for compounded medications;

HB 2613·House·Bill

Rep. My-Linh ThaiState House · LD-41·5 cosponsors

Fiscal noteState YesLocal No

Primary sponsor

My-Linh ThaiState House · LD-41

Cosponsors

Lisa ParshleyState House · LD-22

Davina DuerrState House · LD-01

Sharon Tomiko SantosState House · LD-37

Timm OrmsbyState House · LD-03

Natasha HillState House · LD-03

Legislative history

Jan 21, 2026

First reading, referred to Health Care & Wellness.

Bill text

Bill reports

House Bill Analysis 2026 — Initial House Analysis 01-30-26

Where it stands

In committee — the House

On the floor — the House

In committee — the Senate

On the floor — the Senate

Resolving differences

With the Governor

Became law

Path for a House bill